KalVista Pharmaceuticals, Inc. — Institutional Ownership

Which tracked institutions hold KALV, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

2
Funds holding
$219580
Total value held
Buying
2 added/new · 0 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Janus Henderson Group Plc $219526 10900 +10900 NEW BUY
2 Amalgamated Financial Corp. $54 3652 +3652 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.